Therapeutic Product Effect Decreased
13 drugs3,970 FAERS reportsMedDRA PT
GET
/api/v1/reaction/therapeutic-product-effect-decreasedReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Therapeutic Product Effect Decreased (13)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Aluminum Acetate1640%
- 2Gold1,20419%
- 3Diatrizoate5811%
- 4Benzethonium178.4%
- 5Sincalide117.2%
- 6Fluciclovine44.0%
- 7Valbenazine8603.5%
- 8Tasimelteon1963.4%
- 9Erenumab1,2712.4%
- 10Rimegepant2351.9%
- 11Flibanserin311.6%
- 12Ritlecitinib251.4%
- 13Boric Acid42—
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Middle Insomnia2 shared · 0.12
- Therapeutic Product Effect Incomplete6 shared · 0.09
- Therapeutic Response Unexpected2 shared · 0.08
- Contraindicated Product Administered3 shared · 0.08
- Musculoskeletal Stiffness2 shared · 0.06
- Sleep Disorder2 shared · 0.06
- Product Dose Omission2 shared · 0.05
- Arthropathy2 shared · 0.04
- Rheumatoid Arthritis3 shared · 0.04
- Adverse Drug Reaction2 shared · 0.04
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.